
Nucleosides
Found 3569 products of "Nucleosides"
9-(2'-C-methyl-b-D-ribofuranosyl)6-methylpurine
CAS:9-(2'-C-methyl-b-D-ribofuranosyl)6-methylpurine is a modified monophosphate nucleoside that is an antiviral agent. It can be used as a building block for the synthesis of ribonucleosides, deoxyribonucleosides, and phosphoramidites. This product has been shown to have anticancer properties and may be used in the development of new anticancer drugs. 9-(2'-C-methyl-b-D-ribofuranosyl)6-methylpurine has also been shown to inhibit the growth of bacteria by inhibiting DNA synthesis.Purity:Min. 95%7-Deaza-2'-deoxy-7-iodoguanosine
CAS:7-Deaza-2'-deoxy-7-iodoguanosine is a purine nucleoside that is synthesized from guanosine and iodine. It is used as a marker in sequencing reactions because it can be easily detected by UV light at 254 nm. 7-Deaza-2'-deoxy-7-iodoguanosine can be synthesized using the following general equation:
Formula:C11H13IN4O4Purity:Min. 97 Area-%Color and Shape:White PowderMolecular weight:392.16 g/molN2-DMF-5'-O-DMT-2'-O-methylguanosine 3'-CE phosphoramidite
N2-DMF-5'-O-DMT-2'-O-methylguanosine 3'-CE phosphoramidite is a novel ribonucleotide with high purity and high quality. It is an activator of DNA synthesis and can be used in the synthesis of DNA, monophosphate, and diphosphate. N2-DMF-5'-O-DMT-2'-O-methylguanosine 3'-CE phosphoramidite is used for the preparation of anticancer drugs, antiviral agents, and other nucleosides.Formula:C44H55N8O8PPurity:Min. 95%Color and Shape:White PowderMolecular weight:854.95 g/mol3’-Deoxy-3’-fluoro-N6-hydroxyadenosine
CAS:3’-Deoxy-3’-fluoro-N6-hydroxyadenosine (3'-DF) is an antiviral nucleoside that inhibits viral DNA synthesis and has shown cytotoxic effects in human cancer cells. 3'-DF is a novel chemical compound that was first synthesized in 1994. It is a nucleotide analog that is structurally related to adenosine, with the exception of the fluoro atom at position 6 on the ribose sugar. 3'-DF inhibits DNA polymerase and RNA polymerase by competitively binding to the ribonucleotide reductase enzyme, inhibiting the production of new RNA and DNA molecules. This compound also has been shown to inhibit protein synthesis in cancer cells without affecting normal cells.Purity:Min. 95%N6-Benzoyl-9-(2'-deoxy-5’-O-DMT-2’-fluoro-b-D-arabinofuranosyl)adenine 3’-CE-phosphoramidite
CAS:N6-Benzoyl-9-(2'-deoxy-5’-O-DMT-2’-fluoro-b-D-arabinofuranosyl)adenine 3’-CE-phosphoramidite is an antiviral agent that inhibits the replication of DNA. This compound was synthesized in the laboratory, and has not been found in nature. N6-Benzoyl-9-(2'-deoxy-5’-O--DMT--2’--fluoro--b--D--arabinofuranosyl)adenine 3’--CE--phosphoramidite is a novel compound that is effective against HIV and other viruses. It also has anticancer properties, which may be due to its ability to inhibit the transcription of genes involved in cell proliferation.Purity:Min. 95%3-N-Boc-5'-O-DMT-3'-fluorothymidine
CAS:3-N-Boc-5'-O-DMT-3'-fluorothymidine is a monophosphate nucleoside with antiviral and anticancer activity. It is a novel synthetic analogue of fluoro thymidine (FT) that has been shown to be an activator of DNA polymerase α, RNA polymerase β and γ, and protein kinase C. This compound is also an inhibitor of the reverse transcriptase enzyme HIV-1. 3-N-Boc-5'-O-DMT-3'-fluorothymidine has been shown to inhibit cancer cell growth in vitro and in vivo. The synthesis of this compound can be achieved by phosphoramidite chemistry using a commercially available automated synthesizer.Purity:Min. 95%4’,5’-Didehydro-5’-deoxy-5-methyluridine
CAS:4’,5’-Didehydro-5’-deoxy-5-methyluridine is a monophosphate nucleoside that is used as an antiviral agent. It has been shown to be active in the treatment of HIV and hepatitis B. 4’,5’-Didehydro-5’-deoxy-5-methyluridine also has anticancer properties and has been shown to inhibit cell proliferation in vitro by interfering with DNA synthesis. This product is an intermediate for the synthesis of other nucleosides and phosphoramidites.Purity:Min. 95%N4-Benzoyl-2'-deoxy-5'-O-pixylcytidine
CAS:N4-Benzoyl-2'-deoxy-5'-O-pixylcytidine is a novel nucleoside that is structurally related to cytidine. It is synthesized from 2'-deoxycytidine monophosphate and 4-benzoylpixyl chloride. N4-Benzoyl-2'-deoxy-5'-O-pixylcytidine has antiviral, antiangiogenic and anticancer properties, as well as the ability to inhibit the replication of DNA in cells. This compound can be used for synthesis of phosphoramidites, which are used in the production of oligonucleotides.Formula:C35H29N3O6Purity:Min. 95%Molecular weight:587.64 g/mol2'-O-(N-Methylanthraniloyl)-3'-deoxy-adenosine-5'-triphosphate triethylammonium salt
CAS:2'-O-(N-Methylanthraniloyl)-3'-deoxy-adenosine-5'-triphosphate triethylammonium salt is a novel antiviral and anticancer compound. It is an analogue of adenosine, which inhibits the synthesis of viral RNA and DNA. This compound can also be used to treat certain types of cancer. 2'-O-(N-Methylanthraniloyl)-3'-deoxy-adenosine-5'-triphosphate triethylammonium salt is chemically synthesized by reacting anthranilic acid with 3',5'-dideoxyadenosine 5' triphosphoric acid.Formula:C18H23N6O13P3Purity:Min. 95%Molecular weight:624.33 g/molN2-Isobutyryl-2'-deoxy-5'-O-pixylguanosine
N2-Isobutyryl-2'-deoxy-5'-O-pixylguanosine is a modified nucleotide that has been shown to be an activator of the protein kinase C and may have anticancer and antiviral properties. N2-Isobutyryl-2'-deoxy-5'-O-pixylguanosine is a synthetic nucleoside that is structurally similar to ribonucleosides and deoxyribonucleosides, but contains a modified base. The nucleotide is activated by phosphorylation and then undergoes hydrolysis in the cell to form diphosphate. This product has CAS No. 125965-04-3, purity at 99%, and high quality.Formula:C33H31N5O6Purity:Min. 95%Molecular weight:593.64 g/mol2-Methylthio-N6-isopentenyladenosine
CAS:A nucleoside analogue of adenosine that arises from post-transcriptional modification. In humans, this is mediated by the enzyme CDK5RAP1 in mitochondrial transfer RNA (tRNA) at amino acid 37. Deficiency for this modification, for example due to CDK5RAP1 deficiency, leads to impaired mitochondrial protein synthesis. This has implications for mitochondrial diseases, as well as cancer, type II diabetes and vitiligo. Synthetic ms2i6A can be used to raise monoclonal antibodies against this nucleotide in vivo.Formula:C16H23N5O4SPurity:Min. 95%Color and Shape:White PowderMolecular weight:381.45 g/mol2,4-bis(Benzyloxy)-6-chloropyrimidine
CAS:This study investigates the association between the use of 2,4-bis(benzyloxy)-6-chloropyrimidine (BCP) and lowering in the risk of developing breast cancer in women. The study is based on a national dataset that includes all Danish women who were enrolled in the Danish Breast Cancer Screening Program from 1995 to 2009. The covariates collected include age, weight, height, family history of breast cancer, parity, and hormone replacement therapy. This research was conducted by researchers at various universities in Denmark.Purity:Min. 95%1-(b-L-Arabinofuranosyl)uracil 5'-triphosphate triethylammonium salt
1-(b-L-Arabinofuranosyl)uracil 5'-triphosphate triethylammonium salt is a novel antiviral agent that is synthesized from ribonucleosides. It is an activator of the monophosphate form of RNA polymerase and inhibits the synthesis of DNA in cells. This drug has also been shown to be effective against cancer cells and may be useful for treatment of leukemia.Purity:Min. 95%Guanosine-5'-[(b,gamma)-methyleno]triphosphate sodium salt
CAS:Guanosine-5'-[(b,gamma)-methyleno]triphosphate sodium salt (GMPP) is an analog of guanosine triphosphate that is enzymatically inactivated by the enzyme kinesin. GMPP inhibits the polymerization of microtubules by binding to the kinesin molecule and preventing it from binding to tubulin. GMPP has been shown to inhibit sephadex g-100 chromatography and act as a competitive inhibitor for protein synthesis in vitro. GMPP has also been shown to have a fat cell differentiation effect which may be due to its ability to inhibit microtubule polymerization.Formula:C11H18N5O13P3·xNaPurity:Min. 95 Area-%Color and Shape:PowderMolecular weight:521.21 g/mol2'/3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt
CAS:2'/3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt is an antiviral agent that is based on ribonucleosides. This drug has been shown to be effective against cancer and herpes simplex virus type 1 (HSV-1) and may have potential as a treatment for HIV. It also inhibits the growth of tumors in animal models. 2'/3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt is synthesized by reacting ribonucleosides with N-(2,2,2,-trimethylpropyl)anthranilic acid chloride in the presence of triethylamine. The resulting product can be purified by column chromatography or recrystallization.Formula:C18H21N6O8PPurity:Min. 95%Molecular weight:480.37 g/mol3'-Azido-3'-deoxythymidine 5'-monophosphate sodium salt
CAS:3'-Azido-3'-deoxythymidine 5'-monophosphate sodium salt is a synthetic nucleoside that is structurally related to thymidine. It has antiviral and anticancer properties, as well as the potential for use in gene therapy. 3'-Azido-3'-deoxythymidine 5'-monophosphate sodium salt is active against herpes simplex virus type 1 (HSV-1) and HSV-2, human immunodeficiency virus type 1 (HIV-1), human papillomavirus types 16 and 18 (HPV), Epstein Barr Virus (EBV), and cytomegalovirus (CMV). 3'-Azido-3'-deoxythymidine 5'-monophosphate sodium salt inhibits the production of HIV by preventing the viral reverse transcriptase from synthesizing DNA from RNA.Formula:C10H13N5NaO7PPurity:Min. 95%Molecular weight:369.23 g/mol5-Chloro-2'-deoxycytidine
CAS:5-Chloro-2'-deoxycytidine (5-Cl-dC) is a nucleoside analog that inhibits DNA synthesis by blocking the action of thymidylate synthase. It can be used in animal models to study bowel diseases, such as ulcerative colitis and Crohn's disease. 5-Cl-dC has been shown to be effective in treating the effects of radiation and chemical toxicity in HL60 cells, a type of human leukemia cell line. 5-Cl-dC has also been shown to enhance the cytotoxicity of eosinophil peroxidase, which is an enzyme that may be involved in the pathogenesis of asthma. This drug is currently being evaluated for its safety and efficacy in clinical trials involving patients with myelodysplastic syndrome or acute myeloid leukemia who are at risk for developing leukemia.
Formula:C9H12CIN3O4Purity:Min. 95%Color and Shape:PowderMolecular weight:261.67 g/mol3-(3-Amino-3-carboxypropyl)uridine
CAS:3-(3-Amino-3-carboxypropyl)uridine is an uridine analog that is used in the study of protein synthesis. It can be used to determine the amino acid sequence of a protein, or to identify proteins with similar sequences. 3-(3-Amino-3-carboxypropyl)uridine can also be used to study enzymatic reactions, such as those involved in the synthesis of polypeptides. This molecule has been shown to produce disulfide bonds and form covalent bonds with other molecules. The three-dimensional structure of this molecule has been determined by NMR spectroscopy and X-ray crystallography.
Formula:C13H19N3O8Purity:Min. 95%Color and Shape:PowderMolecular weight:345.31 g/mol3-Deazaadenosine
CAS:A potential role in apoptosis and cellular senescence.Formula:C11H14N4O4Purity:Min. 99 Area-%Color and Shape:PowderMolecular weight:266.26 g/mol4-Amino-6-hydroxypyrazolo(3,4-D)pyrimidine
CAS:4-Amino-6-hydroxypyrazolo(3,4-D)pyrimidine is an anti-inflammatory drug that is used to treat bowel disease. It is also used as a polymer conjugate to treat cancer, and in the prevention of transplant rejection. 4-Amino-6-hydroxypyrazolo(3,4-D)pyrimidine has been shown to have antioxidant properties and may be effective in preventing inflammatory diseases such as inflammatory bowel disease. It has also been shown to act as an antihypertensive agent by inhibiting angiotensin I converting enzyme (ACE).Formula:C5H5N5OPurity:Min. 95%Molecular weight:151.13 g/mol
